Cited by 59Physical Activity and HealthDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial

Open access
Kraus, William E, Yates, Thomas, Tuomilehto, Jaakko, Sun, Jie-Lena, Thomas, Laine, McMurray, John J V, Bethel, M Angelyn, Holman, Rury R·2018·BMJ Open Diabetes Research & Care

Abstract

Objective: Physical activity is related to clinical outcomes, even after adjusting for body mass, but is rarely assessed in randomized clinical trials. Research design and methods: We conducted an observational analysis of data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial, in which a total of 9306 people from 40 countries with impaired glucose tolerance and either cardiovascular disease or cardiovascular risk factors were randomized to receive nateglinide or placebo, in a 2-by-2 factorial design with valsartan or placebo. All were asked to also participate in a detailed lifestyle modification programme and followed-up for a median of 6.4 years with progression to diabetes as a co-primary end point. Seven-day ambulatory activity was assessed at baseline using research-grade pedometers. We assessed whether the baseline amount of physical activity was related to subsequent development of diabetes in individuals with impaired glucose tolerance. Results: Pedometer data were obtained on 7118 participants and 35.0% developed diabetes. In an unadjusted analysis each 2000-step increment in the average number of daily steps, up to 10 000, was associated with a 5.5% lower risk of progression to diabetes (HR 0.95, 95%CI 0.92 to 0.97), with >6% relative risk reduction after adjustment. Conclusions: Physical activity should be measured objectively in pharmacologic trials as it is a significant but underappreciated contributor to diabetes outcomes. It should be a regular part of clinical practice as well.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2018-000523

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The NAVIGATOR study has shown that for every additional 2000 steps/day the risk of developing cardiovascular events decreased by 10%, T2DM by 5.5%, and the metabolic syndrome risk score reduced by 0.29 z-score.

    “In addition, the NAVIGATOR study, which consisted of 9000 individuals with high cardiovascular risk or impaired glucose tolerance, has shown that for every additional 2000 steps/day the risk of developing cardiovascular events decreased by 10%, T2DM by 5.5%, and the metabolic syndrome risk score redcued by 0.29 z-score [70–72].”

    From Can consumer wearable activity tracker-based interventions improve physical activity and cardiometabolic health in patients with chronic diseases? A systematic review and meta-analysis of randomised controlled trials (2020) · cites this paper as [71]

    The Research design and methods section reports 9,306 participants with impaired glucose tolerance and cardiovascular disease or risk factors. The Conclusions report a 5.5% lower diabetes risk per 2,000 additional baseline steps per day. This paper does not report the claimed 10% reduction in cardiovascular events or 0.29 z-score reduction in metabolic syndrome risk; its Discussion mentions a cardiovascular association without that figure. Page numbers were unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kraus, W. E., Yates, T., Tuomilehto, J., Sun, J.-L., Thomas, L., McMurray, J. J. V., Bethel, M. A., & Holman, R. R.
Affiliations
  • Duke University (US)
  • University of Leicester (GB)
  • Universität für Weiterbildung Krems (AT)
  • University of Glasgow (GB)
  • University of Oxford (GB)
Corresponding author
Kraus, William E
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2018-07
Volume
6
Issue
1
Pages
e000523
ISSN
2052-4897 (ISSN-L)
OpenAlex
W2883142186
Cited by
59
References
24
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 12 · 2021: 8 · 2020: 14 · 2019: 10
FWCI
5.50
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • Research Bank (Australian Catholic University) (submittedVersion, cc-by-nc)
  • Figshare (submittedVersion, cc-by-nc)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Leicester Research Archive (University of Leicester) (submittedVersion, cc-by-nc)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081559)
Topics
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
physical activity, pedometers, step count, impaired glucose tolerance, new-onset diabetes, diabetes progression, nateglinide, valsartan, lifestyle modification, cardiovascular risk, objective activity measurement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review